Co-trimoxazole is a
combination antibiotic made up of trimethoprim and sulphamethoxazole that is
first line treatment for Pneumocystis
jirovecii pneumonia (PJP). Hyperkalaemia is a relatively common side effect
of the trimethoprim component of co-trimoxazole but it is not well recognised
by clinicians. The mechanism of action causing hyperkalaemia due to
trimethoprim is similar to the potassium sparing diuretic effect of amiloride.
It has been suggested on this basis that the hyperkalaemia can be reversed by
the administration of furosemide and 0.9% saline to promote kaliuresis. We
present what we believe to be the first published case of successfully managing
trimethoprim induced hyperkalaemia with furosemide and 0.9% saline allowing the
continued use of co-trimoxazole to treat severe PJP.
Cite this paper
Johnstone, J. and Macduff, A. (2014) Successful Conservative Management of Trimethoprim Induced Life-Threatening Hyperkalaemia in a Patient with Pneumocystis jirovecii
Pneumonia. Case Reports in Clinical Medicine
, 469-473. doi: 10.4236/crcm.2014.38103
 Sax, P.E. (2012) Treatment of Pneumocystis Infection in HIV-Infected Patients. Uptodate Article. http://www.uptodate.com/contents/treatment-of-pneumocystis-infection-in-hiv-infected-patients
 Kaufman, A.M., Hellman, G. and Abramson, R.G. (1983) Renal Salt Wasting and Metabolic Acidosis with Trimethoprim-Sulfamethoxazole Therapy. The Mount Sinai Journal of Medicine, 50, 238-239.
 Perazella, M.A. (2000) Trimethoprim-Induced Hyperkalaemia: Clinical Data, Mechanism, Prevention and Management. Drug Safety, 22, 227-236. http://dx.doi.org/10.2165/00002018-200022030-00006
 Safrin, S. and Finkelstein, D.M. (1997) Comparison of Oral Agents for the Treatment of Pneumocystis carinii Pneumonia [Letter]. Annals of Internal Medicine, 126, 407-408 http://dx.doi.org/10.7326/0003-4819-126-5-199703010-00012
 Alappan, R., Buller, G.K. and Perazella, M.A. (1999) Trimethoprim-Sulfamethoxazole Therapy in Outpatients: Is Hyperkalemia a Significant Problem? American Journal of Nephrology, 19, 389-394. http://dx.doi.org/10.1159/000013483
 Velazquez, H., Perazella, M.A., Wright, F.S. and Ellison, D.H. (1993) Renal Mechanism of Trimethoprim-Induced Hyperkalemia. Annals of Internal Medicine, 119, 296-301. http://dx.doi.org/10.7326/0003-4819-119-4-199308150-00008
 Stangoe, D., Jenkins, N. and Coakes, J. (2013) A Case or Refractory Hyperkalaemia in an HIV-Positive Patient with Pneumoncystis jirovecii Pneumonia. JCIS, 14, 259-262.
 Antoniou, T., Gomes, T., Mamdani, M.M., Yao, Z., Hellings, C., Garg, A.X., Weir, M.A. and Juurlink, D.N. (2011) Trimethoprim-Sulfamethoxazole Induced Hyperkalaemia in Elderly Patients Receiving Spironolactone: Nested Case-Control Study. BMJ, 343, Article ID: d5228. http://dx.doi.org/10.1136/bmj.d5228
 Greenberg, S., Reiser, I.W., Chou, S.Y. and Porush, J.G. (1993) Trimethoprim-Sulfamethoxazole Induces Reversible Hyperkalemia. Annals of Internal Medicine, 119, 291-295. http://dx.doi.org/10.7326/0003-4819-119-4-199308150-00007
 Bennett, N.J. (2013) Pneumocystis jirovecii Pneumonia. Emedicine Article.http://emedicine.medscape.com/article/225976-overview